An Irish company is using four American diamondback rattlesnakes in a new clinical trial that will test snake venom as a treatment for cancer. The snakes, which hail from the Albuquerque BioPark, will be allowed to bite something and have their venom extracted humanely. The venom contains proteins that will be extracted and refined to target and kill cancer cells.
Snake venom has long shown promise as a treatment for cancer, in a wide range of animal trials dating back several years. Celtic Biotech isolated a protein in a type of rattlesnake venom that causes malignant cancer cells to commit cell suicide.
Photo by Charles & Clint.
|This Human Dishwasher Can Wash 18,000 Dishes Per Hour|
|Your Teachers Never Had A Whiteboard This Amazing|
|I Want To Take a Dip in This Amazing Technology|
|You Committed Three Felonies Before Breakfast Today|
|Want to be a Skittles Millionaire?|
|How to Sell a Goat with a Story|
|The New Milkman: Coffee Delivered to Your Door|
|All Startups Want VC, But Everyone Already Has Friends and Family|
|Before You Struggle to Put Up Your Christmas Tree, Watch This|
|Is That Drink a Soda, a Pop or a Coke?|